Search results
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 2 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the ...
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 2 days agoBut in later pandemic days, investors started worrying about Moderna's dependence on its only commercialized product, and that has weighed on the stock...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 6 days agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 6 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 1 day agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 6 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 2 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
